AstraZeneca (AZN)

Add to Watchlists
Create an Alert
66.86 -2.24  -3.24% NYSE Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
AZN Price Chart
View All Events

AZN Events

Date Type Description
Nov 06 Earnings AstraZeneca PLC 2014 Third Quarter Earnings Results. Estimate: 1.20.
Jul 31 Earnings AstraZeneca PLC 2014 Second Quarter Earnings Results. Estimate: 1.20.
Apr 24 Earnings AstraZeneca PLC 2014 First Quarter Earnings Results. Estimate: 1.20.
Apr 24 Misc AGM Event for AstraZeneca PLC
Mar 20 Misc AstraZeneca PLC 2013 Annual Report
Feb 19 Dividends Amount: 1.90, Declared Date: Feb 07 2014, Pay Date: Mar 24 2014
Feb 06 Misc Fourth Quarter Earnings Conference Call
Feb 06 Earnings Announcement of Fourth Quarter and Full Year 2013 Results. Estimate: 1.28.
Oct 31 Misc Third Quarter Earnings Conference Call
Oct 31 Earnings Announcement of Third Quarter and Nine Months Results 2014. Estimate: 1.30.
View All Performance Charts

AZN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AstraZeneca is up 36.48% over the last year vs S&P 500 Total Return up 23.42%, GlaxoSmithKline up 14.40%, and Pfizer up 3.11%.

Get Quote for

PDF Report for AZN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AZN Pro Report PDF
Advertisement

Portfolio Strategies Featuring AZN

Did AstraZeneca make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AZN Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: United Kingdom
  • Headquarters State/Province: N/A
  • Incorporation Country: United Kingdom
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013

AstraZeneca plc is a global pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by revenues and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. AstraZeneca PLC markets its products primarily to primary care and specialist doctors, and other healthcare professionals through distributors or local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AZN 66.86 -2.24 -3.24% 84.05B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.